iBio (IBIO) Other Non-Current Assets (2011 - 2026)

iBio's (IBIO) quarterly Other Non-Current Assets came in at $200000.0 in Q1 2026, little changed year-on-year from $200000.0 in Q1 2025, and up 1900.0% on a QoQ basis from $10000.0 in Q4 2025.

iBio (IBIO) Other Non-Current Assets (2011 - 2026) Analysis & Trends

iBio (IBIO) has 12 years of Other Non-Current Assets data on file, last reported at $200000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $26000.0, down 87.91% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $200000.0, up from $10000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for IBIO reached as high as $6.0 million in Q3 2022 and fell as low as $10000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $984882.4 across 5 years, with a median of $223000.0 in 2024.
  • On a YoY basis, Other Non-Current Assets climbed as much as 3962.5% in 2022 and fell as far as 95.74% in 2022.
  • Year by year, Other Non-Current Assets stood at $253000.0 in 2022, then soared by 413.83% to $1.3 million in 2023, then slumped by 82.85% to $223000.0 in 2024, then plunged by 95.52% to $10000.0 in 2025, then soared by 1900.0% to $200000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $200000.0 in Q1 2026, $10000.0 in Q4 2025, and $228000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.02 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 14.48 Mn
10 iBio 172.22 Mn 172.22 Mn - 200,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 10,000.00
Sep 30, 2025 228,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 223,000.00
Sep 30, 2024 223,000.00
Jun 30, 2024 215,000.00
Mar 31, 2024 215,000.00
Dec 31, 2023 1.30 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 50,000.00
Mar 31, 2023 3.30 Mn
Dec 31, 2022 253,000.00
Sep 30, 2022 6.00 Mn
Jun 30, 2022 29,000.00
Mar 31, 2022 975,000.00
Dec 31, 2021 5.94 Mn
Sep 30, 2021 1.30 Mn
Mar 31, 2021 24,000.00